Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors (Q33743457)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Assessment of chimpanzee adenovirus serotype 63 neutralizing antibodies prior to evaluation of a candidate malaria vaccine regimen based on viral vectors (English)

1 reference

Europe PubMed Central

29 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

0 references

malaria vaccine

1 reference

based on heuristic

inferred from title

object named as

Nick J Edwards

2

0 references

Egeruan B Imoukhuede

object named as

Egeruan B Imoukhuede

11

0 references

Adrian V. S. Hill

12

object named as

Adrian V S Hill

1 reference

Europe PubMed Central

29 July 2017

Sodiomon B Sirima

13

object named as

Sodiomon B Sirima

1 reference

Europe PubMed Central

29 July 2017

4

object named as

Katie J Ewer

1 reference

Europe PubMed Central

29 July 2017

8

object named as

Amidou Diarra

1 reference

Europe PubMed Central

29 July 2017

3

object named as

Alfred B Tiono

1 reference

Europe PubMed Central

29 July 2017

Issiaka Soulama

6

object named as

Issiaka Soulama

1 reference

Europe PubMed Central

29 July 2017

1

object named as

Issa Nébié

1 reference

Europe PubMed Central

29 July 2017

Jean Baptiste Yaro

9

object named as

Jean Baptiste Yaro

1 reference

Europe PubMed Central

29 July 2017

Guillaume Sanou

5

object named as

Guillaume S Sanou

1 reference

Europe PubMed Central

29 July 2017

Souleymane Sanon

7

object named as

Souleymane Sanon

1 reference

Europe PubMed Central

29 July 2017

David Tiga Kangoye

10

object named as

David Kangoye

1 reference

Europe PubMed Central

29 July 2017

publication date

16 April 2014

1 reference

Europe PubMed Central

29 July 2017

Clinical and Vaccine Immunology

1 reference

Europe PubMed Central

29 July 2017

21

1 reference

Europe PubMed Central

29 July 2017

6

1 reference

Europe PubMed Central

29 July 2017

901-903

1 reference

Europe PubMed Central

29 July 2017

Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

21 June 2018

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

21 June 2018

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

21 June 2018

Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

21 June 2018

Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

21 June 2018

Phase Ia clinical evaluation of the Plasmodium falciparum blood-stage antigen MSP1 in ChAd63 and MVA vaccine vectors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

21 June 2018

Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

21 June 2018

Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

21 June 2018

Generation of a novel replication-incompetent adenoviral vector derived from human adenovirus type 49: manufacture on PER.C6 cells, tropism and immunogenicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

21 June 2018

Generation of an adenoviral vaccine vector based on simian adenovirus 21.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

21 June 2018

Chimpanzee-origin adenovirus vectors as vaccine carriers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

21 June 2018

Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

21 June 2018

Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

21 June 2018

Identification of adenovirus (ad) penton base neutralizing epitopes by use of sera from patients who had received conditionally replicative ad (addl1520) for treatment of liver tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

21 June 2018

Pain-related modulation of the human motor cortex.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

21 June 2018

Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

21 June 2018

Neutralization of adenoviruses: kinetics, stoichiometry, and mechanisms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

21 June 2018

Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4054245

30 October 2018

Neutralizing antibodies to human and simian adenoviruses in humans and New-World monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/24739980

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/CVI.00723-13

1 reference

Europe PubMed Central

29 July 2017

release_2cs323awebbkzhy6xfuyfryroi

1 reference

https://api.fatcat.wiki/v0/release/2cs323awebbkzhy6xfuyfryroi

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33743457&oldid=1980110610"